Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Diabetes, Cardiovascular Risks, and Lipoproteins

112 та иш

  1. "Metabolik assotsirlangan jigar yog'li kasalliklari (MASLD/MAFLD) strukturasi va demografik ko'rsatkichlari"

    Obidjonov Isroiljon Ismoiljon o`g`li, Qodirov Dilshodbek Abduqahhorovich

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  2. LITERATURE REVIEW ON THE TOPIC "STUDYING THE STRUCTURE OF METABOLIC FATTY LIVER DISEASES ON THE EXAMPLE OF ANDIJAN CITY"

    Isroiljon Obidjonov, Dilshodbek Qodirov, Dilmurod Saliev

    МақолаLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  3. LITERATURE REVIEW ON THE TOPIC "STUDYING THE STRUCTURE OF METABOLIC FATTY LIVER DISEASES ON THE EXAMPLE OF ANDIJAN CITY"

    Isroiljon Obidjonov, Dilshodbek Qodirov, Dilmurod Saliev

    МақолаLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  4. Pediatric NAFLD Epidemiology, Risk Factors and Research Gaps in Uzbekistan and India

    Dinmukhammadieva Dilorom Rakhimjan Kizi, Saurav Sunil Pawshe, Shadiyeva Soadat Ulmasovna

    МақолаLiver Disease Diagnosis and TreatmentAcademia Open20260 иқтибос
    ABI

  5. THE EVALUATION OF THE EFFECTIVENESS OF BARIATRIC SURGERY FOR OBESITY IN PATIENTS WITH CONCOMITANT NON-ALCOHOLIC STEATOHEPATITIS

    Sattarov Oybek Tokhirovich, Jumanazarova Mokhinur Jumanazar Kizi

    МақолаLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  6. THE EVALUATION OF THE EFFECTIVENESS OF BARIATRIC SURGERY FOR OBESITY IN PATIENTS WITH CONCOMITANT NON-ALCOHOLIC STEATOHEPATITIS

    Sattarov Oybek Tokhirovich, Jumanazarova Mokhinur Jumanazar Kizi

    МақолаLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  7. QANDLI DIABETDA HbA1c KO‘RSATKICHINING KLINIK AHAMIYATI

    Yulduzxon Fayzullayeva, Maftuna Yusupova

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsQO‘QON UNIVERSITETI XABARNOMASI20260 иқтибос
    ABI

  8. ADVANTAGES AND DISADVANTAGES OF EXPERIMENTAL DIABETES INDUCTION MODELS

    Lobar Ibrohim qizi Ibrohimova, L.SH. Kambarova, Z.O. Ergasheva

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsOpen MIND20260 иқтибос
    ABI

  9. ADVANTAGES AND DISADVANTAGES OF EXPERIMENTAL DIABETES INDUCTION MODELS

    Lobar Ibrohim qizi Ibrohimova, L.SH. Kambarova, Z.O. Ergasheva

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  10. Central obesity and glycaemic control in newly diagnosed type 2 diabetes mellitus patients: evidence from Uzbekistan

    Shukhrat Ziyadullaev, Shokhista Eshmuradova, Jonibek Kadirov +3

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsBMC Endocrine Disorders20260 иқтибос
    ABI

  11. Association of Waistline Measurements with Hypertension in Type II Diabetic Patients in Bihar.

    Saniya Siddiqua, Kalash Dwivedi, Jainil Sejpal +5

    МақолаBlood Pressure and Hypertension StudiesInternational Journal of Contemporary Medicine20260 иқтибос
    ABI

  12. Analysis of adult non-communicable disease (NCD) screening data in Uzbekistan using the UZ-SPEED NCD tool

    Khasanjon Odilov, Odgerel Chimed‐Ochir, Yui Yumiya +7

    МақолаHealth Promotion and Cardiovascular PreventionPublic Health20260 иқтибос
    ABI

  13. DIFFERENTIAL ASSOCIATIONS BETWEEN PHYSICAL ACTIVITY AND GLYCEMIC CONTROL ACROSS BODY MASS INDEX IN TYPE 2 DIABETES: A COMPARATIVE ANALYSIS OF HBA1C AND FRUCTOSAMINE.

    M Ismail, M. M. Hassan, M Khalid +14

    МақолаDiet, Metabolism, and DiseasePubMed20260 иқтибос
    ABI

  14. Pathomorphological Alterations of The Gastric Mucosa in Individuals with Metabolic Syndrome and A Body Mass Index Ranging From 27.5 To 34.9 Kg/M²

    Farrukh Saidaliyevich Akbarov, Nosirjon Juraevich Mahkamov

    МақолаBariatric Surgery and OutcomesAmerican Journal Of Biomedical Science & Pharmaceutical Innovation20260 иқтибос
    ABI

  15. Audit of Inpatient Monitoring and Management of Hypoglycemia in Diabetic Patients Compared to National Guidelines

    Saleem Shah, Sheraz Khan, Ubaid Ur Rahman +4

    МақолаHyperglycemia and glycemic control in critically ill and hospitalized patientsIndus journal of bioscience research.20260 иқтибос
    ABI

  16. MORPHOLOGICAL PREDICTORS OF VASCULAR COMPLICATIONS IN METABOLIC SYNDROME: AN ANATOMICAL PERSPECTIVE

    Mehriniso Mengli kizi Begimova, Og'abek Khusan ugli Eshqovulov, kho'janbek Chori ugli Tursunov +2

    МақолаCardiovascular Health and Disease PreventionZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  17. MORPHOLOGICAL PREDICTORS OF VASCULAR COMPLICATIONS IN METABOLIC SYNDROME: AN ANATOMICAL PERSPECTIVE

    Mehriniso Mengli kizi Begimova, Og'abek Khusan ugli Eshqovulov, kho'janbek Chori ugli Tursunov +2

    МақолаCardiovascular Health and Disease PreventionZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  18. EARLY STRUCTURAL AND FUNCTIONAL CHANGES OF THE MYOCARDIUM IN PATIENTS WITH METABOLIC SYNDROME: A CLINICO-MORPHOLOGICAL ANALYSIS

    Nigoraxon Ravshanbek kizi Madraximova

    МақолаCardiovascular Function and Risk FactorsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  19. EARLY STRUCTURAL AND FUNCTIONAL CHANGES OF THE MYOCARDIUM IN PATIENTS WITH METABOLIC SYNDROME: A CLINICO-MORPHOLOGICAL ANALYSIS

    Nigoraxon Ravshanbek kizi Madraximova

    МақолаCardiovascular Function and Risk FactorsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  20. TYPE 2 DIABETES MELLITUS: GLOBAL EPIDEMIOLOGICAL TRENDS, MOLECULAR MECHANISMS AND RISK FACTORS WITH SPECIAL REFERENCE TO UZBEKISTAN

    D.R. Pazliddinova, I.R. Nusratullayev, A.V. Pazliddinov

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  21. TYPE 2 DIABETES MELLITUS: GLOBAL EPIDEMIOLOGICAL TRENDS, MOLECULAR MECHANISMS AND RISK FACTORS WITH SPECIAL REFERENCE TO UZBEKISTAN

    D.R. Pazliddinova, I.R. Nusratullayev, A.V. Pazliddinov

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  22. DIABETES: AN EMERGING CRISIS

    Shahid Anjum, Khan Nasreen, Sahista Banu +1

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  23. DIABETES: AN EMERGING CRISIS

    Shahid Anjum, Khan Nasreen, Sahista Banu +1

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  24. A MULTIFACTORIAL MODEL FOR PREDICTING SUBCLINICAL ATHEROSCLEROSIS IN MILITARY PERSONNEL: THE CONTRIBUTION OF CRP, HOMA-IR, AND CAVI

    Dildora Narzullayeva

    МақолаPeripheral Artery Disease ManagementScientific and Innovative Therapy20260 иқтибос
    ABI

  25. Global survey of genetic testing methods for familial hypercholesterolaemia: a study and recommendations from the European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration registry

    Joana Rita Chora, Irene Karungi, Amany Elshorbagy +70

    МақолаLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology20260 иқтибос
    ABI